[INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS].
作者信息
BERNARD J, BOUSSER J, DREYFUS B, HAMBURGER J, PEQUIGNOT H
出版信息
Presse Med (1893). 1964 Jan 18;72:167-9.
PMID:14106785
Abstract
摘要
相似文献
1
[INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS].
Presse Med (1893). 1964 Jan 18;72:167-9.
2
INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
Acta Haematol. 1964 Apr;31:239-46. doi: 10.1159/000209633.
3
EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
J Natl Cancer Inst. 1964 Nov;33:753-63. doi: 10.1093/jnci/33.5.753.
4
[HEMORRHAGIC SYNDROME IN LABOR].
Geburtshilfe Frauenheilkd. 1963 Nov;23:1026.
5
ACUTE FIBRINOLYTIC STATES IN SURGERY.
Proc R Soc Med. 1965 Apr;58(4):259-61. doi: 10.1177/003591576505800427.
6
[PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES].
Clin Ter. 1963 Oct 31;27:97-114.
7
THE STABILITY OF FIBRINOLYTIC INHIBITORS IN HUMAN SERUM AND THE INHIBITOR CONTENT IN ANIMAL SERA.
Scand J Clin Lab Invest. 1964;16:614-6. doi: 10.3109/00365516409055224.
8
AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
Am J Med Sci. 1965 May;249:576-89. doi: 10.1097/00000441-196505000-00012.
9
[THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
Acta Biol Med Ger. 1964;12:522-4.
10
[ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
Dtsch Gesundheitsw. 1964 May 14;19:900-3.
Zotero 插件